Latest news
Weekly Recap: ANDA for generic Advair Diskus and Q1 profit down 34% - TradingViewTradingView · Mon, 03 Aug 2026 01:14:00 GMTCipla's US Milestone Gets The Street Talking. Analysts See Bigger Opportunity Ahead - NDTV ProfitNDTV Profit · Wed, 29 Jul 2026 07:00:00 GMTCipla rises 2.7% after USFDA approval for generic Advair; Nomura sees sales upside - Moneycontrol.comMoneycontrol.com · Wed, 29 Jul 2026 07:00:00 GMTCipla Receives U.S. FDA Approval for Generic Advair Diskus® - PR NewswirePR Newswire · Tue, 28 Jul 2026 12:00:00 GMTCipla receives US FDA approval for Generic Advair Diskus - Express PharmaExpress Pharma · Tue, 28 Jul 2026 08:41:21 GMTUS FDA approves Cipla's generic Advair Diskus across all three strengths - Indian Pharma PostIndian Pharma Post · Tue, 28 Jul 2026 07:00:00 GMTCipla surges on getting USFDA`s approval for Generic Advair Diskus - Investment GuruInvestment Guru · Tue, 28 Jul 2026 07:00:00 GMTCipla Secures USFDA Approval for $908 Million Generic Advair Diskus Opportunity - Trade BrainsTrade Brains · Tue, 28 Jul 2026 07:00:00 GMT